Methods of treating a canine and inhibiting NGF activity through use of anti-NGF antibodies
US12084506B2 · kind B2 · utility
0Cited by
126References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2021 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Nov 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment of NGF related disorders, particularly in for the management of pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.